Pulmonary Hypertension clinical trials
64 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension
- A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Bioenergetic Effect of Pioglitazone in CLD-PH
- Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
- iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
- Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
- LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
- Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
- Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
- Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
- Ventilator Pressure and Optimization of Compliance and Hemodynamics
- Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
- Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Feasibility of Semaglutide in Advanced Lung Disease
- Safety and Efficacy of FETO in CDH Phase III
- A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- COMPARE-VENT Feasibility Pilot Study
- Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Xenon MRI Pulm Hypertension
- Pulmonary Hypertension SOLAR
- Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- Use of Hyperpolarized 129Xe MR Lung Imaging in Infants
- Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- CVD/PH and Voice Characteristics
- Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension
- Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
- Real World Observational Study of Sotatercept for Pulmonary Hypertension
- DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
- Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients
- Pulmonary Hemodynamics During Exercise - Research Network
- Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
- Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
- Pulmonary Hypertension in Left Heart Disease
- Pulmonary Hypertension Association Registry
- LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
- Triple EIT (Electrical Impedance Tomography)
- Rutgers University Study of the Genetics of Pulmonary Hypertension
- The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
- Pulmonary Hypertension Biorepository and Registry
- Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
- New Orleans Pulmonary Hypertension Biobank
- Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Pulmonary Hypertension” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.